Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial
PaperCitations, authors & open-access status
Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 481 citations, 2019 year and closed oa status.
481
Citations
2019
Year
closed
OA Status